What the research shows
- BPC-157: 11 of 12 reported knee pain improvement
- TB-500: studied for wound repair in aged mice
- BPC-157: studied for stomach ulcer healing
Published study results for the compound, not results from this product. For research use only.
This equal-mass 3mL blend is labelled with 25mg BPC-157, a synthetic 15-residue peptide, and 25mg TB-500. FDA substance records define TB-500 as the acetylated LKKTETQ fragment associated with thymosin beta-4 research, not full-length thymosin beta-4; the pen provides no sequence or salt specification. No batch-specific independent report is linked, so component identity, quantity and purity are unverified.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare Pre-Filled Pen Premixed Aqueous
SpecsBPC-157 + TB-500 50mg Total (25mg + 25mg) AQ Pen
Studied for tendon repair as a combination
AED 1,000 / pen
Choose your bundle
Minimum order is AED 400
25% off orders of AED 700+ with code KV25 at checkout
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Ships from Dubai
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | BPC-157 + TB-500 |
| Catalogue strength | 50 mg total (25 mg + 25 mg) |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |



